Education
About Us
Working with TipRanks
Follow Us
Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
Total Valuation
Boundless Bio Inc. has a market cap or net worth of $27.65M. The enterprise value is -$39.86M.
Market Cap$27.65M
Enterprise Value-$39.86M
Share Statistics
Boundless Bio Inc. has 22.30M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22.30M
Owned by Insiders22.65%
Owned by Instutions27.71%
Financial Efficiency
Boundless Bio Inc.’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -36.95%.
Return on Equity (ROE)-43.39%
Return on Assets (ROA)-31.67%
Return on Invested Capital (ROIC)-36.95%
Return on Capital Employed (ROCE)-36.95%
Revenue Per Employee$0
Profits Per Employee-$954,046.875
Employee Count64
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Boundless Bio Inc. is -0.75. Boundless Bio Inc.’s PEG ratio is -0.01.
PE Ratio-0.75
PS Ratio0.00
PB Ratio0.33
Price to Fair Value0.33
Price to FCF-0.78
Price to Operating Cash Flow-0.81
PEG Ratio-0.01
Income Statement
In the last 12 months, Boundless Bio Inc. had revenue of $0.00 and earned -$61.06M in profits. Earnings per share was -$2.75.
Revenue$0.00
Gross Profit-$775.00K
Operating Income-$68.78M
Pretax Income-$61.06M
Net Income-$61.06M
EBITDA-67.75M
Earnings Per Share (EPS)-2.75
Cash Flow
In the last 12 months, operating cash flow was -$56.96M and capital expenditures -$2.34M, giving a free cash flow of -$59.30M billion.
Operating Cash Flow-$56.96M
Free Cash Flow-$59.30M
Free Cash Flow per Share-$2.66
Dividends & Yields
Boundless Bio Inc. pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-128.67%
Earnings Yield-132.71%
Stock Price Statistics
Beta2.03
52-Week Price Change-87.22%
50-Day Moving Average1.75
200-Day Moving Average2.82
Relative Strength Index (RSI)34.11
Average Volume (3m)85.43K
Important Dates
Boundless Bio Inc. upcoming earnings date is May 19, 2025, After Close.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Boundless Bio Inc. as a current ratio of 18.98, with Debt / Equity ratio of 0.32
Current Ratio18.98
Quick Ratio18.98
Debt to Market Cap0.97
Net Debt to EBITDA-0.29
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Boundless Bio Inc. has paid -$1.40M in taxes.
Income Tax-$1.40M
Effective Tax Rate0.00%
Enterprise Valuation
Boundless Bio Inc. EV to EBITDA ratio is -0.96, with an EV/FCF ratio of -1.11.
EV to Sales0.00
EV to EBITDA-0.96
EV to Free Cash Flow-1.11
EV to Operating Cash Flow-1.16
Balance Sheet
Boundless Bio Inc. has $167.13M in cash and marketable securities with $121.00K in debt, giving a net cash position of -$167.01M billion.
Cash & Marketable Securities$167.13M
Total Debt$121.00K
Net Cash-$167.01M
Net Cash Per Share-$7.49
Tangible Book Value Per Share$8.87
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Boundless Bio Inc. is $15.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$15.00
Price Target Upside1109.68%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast